Condition
Sepsis and Septic Shock clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Sepsis and Septic Shock clinical trials that are recruiting, at sites in 6 countries (most in Switzerland (2), Hong Kong (1), Australia (1)). By phase: Phase 2 (1), Phase 4 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 6Countries
Newest Sepsis and Septic Shock clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MiRNA markers in septic shock patients | — | Bern | Recruiting | May 19, 2026 |
| Dynamic SvO2 to predict fluid responsiveness in septic shock | — | Menouf | Recruiting | Apr 7, 2026 |
| Adjunctive Fludrocortisone in Septic Shock | Phase 2 | Hong Kong and 4 other locations | Recruiting | Mar 5, 2026 |
| Ceftazidime (±avibactam) with IV fosfomycin versus ceftazidime alone for hospitalized adults with severe suspected Gram‑negative infection | Phase 3 | Geneva, Canton of Geneva | Recruiting | Jul 14, 2025 |
| Education on Immunosuppressive Therapy Reduction in Kidney Transplant Recipients in ICU with Sepsis or Respiratory Failure | Phase 4 | Strasbourg | Recruiting | Mar 18, 2025 |
| Investigating how transposable elements affect immune aging in sepsis patients | — | San Francisco, California | Recruiting | Feb 5, 2025 |
| Assessing blood clotting issues in patients with sepsis and trauma | — | Canberra, Australian Capital Territory and 3 other locations | Recruiting | Nov 8, 2024 |
All recruiting trials (7)
-
MiRNA markers in septic shock patients
This study tests whether microRNA patterns can help explain changes in immune marker HLA-DR on monocytes in adults with septic shock.
-
Dynamic SvO2 to predict fluid responsiveness in septic shock
This study tests whether dynamic central venous oxygen saturation can predict which septic shock patients will respond to fluid boluses.
-
Adjunctive Fludrocortisone in Septic Shock
This study tests adding fludrocortisone to usual care for adults with septic shock to see if it helps patients survive and recover better.
-
Ceftazidime (±avibactam) with IV fosfomycin versus ceftazidime alone for hospitalized adults with severe suspected Gram‑negative infection
This trial will test whether adding intravenous fosfomycin to ceftazidime (or ceftazidime‑avibactam) helps hospitalized adults with suspected severe Gram‑negative infections recover faster than ceftazidime alone.
-
Education on Immunosuppressive Therapy Reduction in Kidney Transplant Recipients in ICU with Sepsis or Respiratory Failure
In kidney transplant patients who are in the ICU for septic shock or severe respiratory failure, the study will test a targeted approach to adjust immunosuppressive therapy and provide education to support safer care.
-
Investigating how transposable elements affect immune aging in sepsis patients
This study looks at how certain genetic elements might affect the immune system and health outcomes in people with sepsis in the ICU.
-
Assessing blood clotting issues in patients with sepsis and trauma
This study is testing a new way to identify patients with sepsis or trauma who are at risk for dangerous blood clots and see if new blood-thinning medications can help improve their treatment.
Related topics
Quick answers
How many Sepsis and Septic Shock clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Switzerland (2 trials), Hong Kong (1 trial), Australia (1 trial), France (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.